Return-to-Duty Drug Test: How the DOT RTD Test Works

A return-to-duty (RTD) test is the DOT drug and/or alcohol test required before a driver can resume safety-sensitive work after completing the substance abuse professional (SAP) process. The SAP must first determine that the driver has successfully complied with the recommended education or treatment. The driver then needs a verified negative drug result and/or an alcohol concentration below 0.02, as applicable.

For FMCSA-regulated CDL and CLP drivers, the negative RTD result must also be reported to the FMCSA Clearinghouse. That changes the driver’s Clearinghouse status from prohibited to not prohibited. It makes the driver eligible to resume safety-sensitive work, but it does not require an employer to hire or return the driver to duty.

When the RTD test can take place

The RTD test cannot take place until the SAP’s follow-up evaluation determines that the driver has successfully complied with the prescribed education or treatment. The SAP provides the required written report, and for CDL and CLP drivers records the date the driver became eligible for RTD testing in the FMCSA Clearinghouse.

An RTD test taken before successful SAP compliance does not satisfy the return-to-duty requirement.

The employer normally arranges the test. This may be the driver’s existing carrier or a prospective employer that intends to return the driver to safety-sensitive work.

FMCSA also allows a driver who does not have a current or prospective Part 382 employer to use a C/TPA for the limited purpose of completing the RTD test and having the negative result reported. The driver must use the applicable Clearinghouse registration process and designate the C/TPA. Owner-operators normally handle their testing program through a DOT drug and alcohol consortium.

How the test is collected

The required test depends on what is required under the return-to-duty process.

• Drug test: a DOT RTD drug collection must be directly observed. Under the current urine observation rule, the observer must be the same sex as the employee and must follow the Part 40 direct-observation procedure. Declining a required directly observed collection is a refusal to test.
• Alcohol test: when an RTD alcohol test is required, the alcohol concentration must be less than 0.02 before the driver can resume safety-sensitive duties.
• Drug and alcohol: the return-to-duty requirement can involve drug testing, alcohol testing or both.

An RTD drug test uses the Federal Drug Testing Custody and Control Form and goes through an HHS-certified laboratory and medical review officer (MRO). The reason for test must be identified as return-to-duty. An alcohol test uses the DOT alcohol-testing procedures and Alcohol Testing Form.

For a drug test, the required outcome is a verified negative result. A verified positive, adulterated or substituted result, or another refusal to test, creates a new DOT violation and requires a new SAP return-to-duty process. The normal Part 40 procedures, including applicable split-specimen rights following an MRO-verified positive, adulterated or substituted drug result, still apply.

After the result: Clearinghouse, CDL status and cost

For an FMCSA-regulated driver, the employer or authorized C/TPA reports the negative RTD result to the Clearinghouse. Once that information is entered, the driver’s Clearinghouse status changes from prohibited to not prohibited.

That status change removes the FMCSA drug and alcohol prohibition, but it does not guarantee employment. Part 40 leaves the decision to return or hire the driver to the employer.

There is also a separate CDL issue. Since November 18, 2024, State Driver Licensing Agencies are required to remove commercial driving privileges for drivers who remain in prohibited Clearinghouse status. If a driver’s CDL or CLP has already been downgraded, becoming not prohibited allows the driver to seek reinstatement of commercial driving privileges through the applicable state licensing agency. The Clearinghouse status change itself should not be treated as confirmation that every state licensing step is complete.

Who pays for the RTD test depends on the employer’s policy or agreement with the driver. DOT regulations do not generally assign SAP or RTD costs to one side. Drivers moving to a new carrier should establish who will pay before the test is scheduled.

Carriers already using a clinic or collection network for DOT pre-employment drug testing may be able to use the same network for RTD testing, but the provider must be able to perform the required DOT RTD collection correctly.

RTD test vs follow-up testing

The RTD test gets the driver through the testing stage required before returning to safety-sensitive duty. Follow-up testing starts after the return to safety-sensitive work.

• Timing: RTD testing occurs before the driver resumes safety-sensitive functions. Follow-up testing takes place afterward.
• Frequency: the SAP must prescribe at least six unannounced follow-up tests during the first 12 months of safety-sensitive duty. Testing can continue for up to another 48 months.
• Test type: the SAP determines whether follow-up testing will involve drugs, alcohol or both.
• Observation: follow-up drug tests, like RTD drug tests, require direct observation.
• Scheduling: the SAP sets the number and frequency of follow-up tests, but the employer selects the actual test dates. The schedule must not be disclosed to the driver.
• Other tests: follow-up testing is separate from random, post-accident, reasonable-suspicion and other testing required under Part 382.
• Changing employers: the follow-up requirement follows the driver. A subsequent DOT employer is responsible for carrying out the remaining SAP-prescribed testing while the driver performs safety-sensitive work.

A side-by-side breakdown is in return-to-duty test vs follow-up testing. For the complete sequence, see the DOT return-to-duty process. If the violation has just occurred, see what happens if you fail a DOT drug test. The collection and observation rules are in 49 CFR Part 40).